HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Intech Investment Management LLC

Intech Investment Management LLC decreased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 16.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 169,283 shares of the company’s stock after selling 33,880 shares during the quarter. HCA Healthcare makes up 0.8% of Intech Investment Management LLC’s holdings, making the stock its 15th biggest position. Intech Investment Management LLC’s holdings in HCA Healthcare were worth $68,802,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of HCA. Acadian Asset Management LLC boosted its position in HCA Healthcare by 115.5% during the first quarter. Acadian Asset Management LLC now owns 3,372 shares of the company’s stock worth $1,123,000 after acquiring an additional 1,807 shares during the last quarter. Bessemer Group Inc. boosted its position in HCA Healthcare by 51.2% during the first quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock worth $2,543,000 after acquiring an additional 2,584 shares during the last quarter. CreativeOne Wealth LLC purchased a new position in HCA Healthcare during the first quarter worth about $231,000. Advisors Asset Management Inc. raised its stake in HCA Healthcare by 117.5% during the first quarter. Advisors Asset Management Inc. now owns 2,543 shares of the company’s stock worth $848,000 after purchasing an additional 1,374 shares during the period. Finally, Toronto Dominion Bank raised its stake in HCA Healthcare by 1.4% during the first quarter. Toronto Dominion Bank now owns 114,189 shares of the company’s stock worth $38,085,000 after purchasing an additional 1,593 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HCA has been the topic of a number of analyst reports. Oppenheimer lifted their target price on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research note on Monday, October 28th. TD Cowen reduced their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Morgan Stanley initiated coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target on the stock. Finally, UBS Group boosted their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Five analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $385.00.

HCA Healthcare Trading Down 0.6 %

NYSE HCA opened at $333.00 on Thursday. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 52 week low of $245.84 and a 52 week high of $417.14. The stock has a market capitalization of $84.35 billion, a PE ratio of 14.95, a price-to-earnings-growth ratio of 1.29 and a beta of 1.68. The firm has a 50 day moving average of $381.99 and a two-hundred day moving average of $358.12.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.79%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

Insider Activity

In related news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares in the company, valued at $2,415,579. This represents a 29.76 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,155 shares of company stock worth $5,608,990. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.